0001567619-22-021667.txt : 20221215
0001567619-22-021667.hdr.sgml : 20221215
20221215182245
ACCESSION NUMBER: 0001567619-22-021667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221213
FILED AS OF DATE: 20221215
DATE AS OF CHANGE: 20221215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mueller Brian
CENTRAL INDEX KEY: 0001514980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 221466009
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2022-12-13
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001514980
Mueller Brian
105 DIGITAL DRIVE
NOVATO
CA
94949
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2022-12-13
4
M
0
2500
63.10
A
30246
D
Common Stock
2022-12-13
4
S
0
2500
107.500
D
27746
D
Stock Option (Right to buy Common Stock)
63.10
2022-12-13
4
M
0
2500
0
D
2014-12-04
2024-06-03
Common Stock
2500
7500
D
Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2022-12-15